Provided by Tiger Trade Technology Pte. Ltd.

HANSOH PHARMA

32.240
-1.680-4.95%
Volume:11.16M
Turnover:368.50M
Market Cap:195.50B
PE:29.61
High:34.560
Open:34.040
Low:32.200
Close:33.920
52wk High:43.587
52wk Low:27.658
Shares:6.06B
HK Float Shares:6.06B
Volume Ratio:1.41
T/O Rate:0.18%
Dividend:0.49
Dividend Rate:1.50%
EPS(LYR):1.089
ROE:19.40%
ROA:9.08%
PB:4.42
PE(LYR):29.61
PS:10.50

Loading ...

China's Zhaoke Ophthalmology H1 Revenue Rises

Reuters
·
Aug 28

China's CStone Pharmaceuticals H1 Revenue Soars on Drug Sales

Reuters
·
Aug 27

China's JW Therapeutics Interim Revenue Rises 4.7% on Carteyva Sales

Reuters
·
Aug 27

Goldman Sachs Boosts HANSOH PHARMA Price Target on Strong First-Half Results

Stock News
·
Aug 27

Why Hansoh Pharma Surged Over 16% After Its Earnings Report?

Deep News
·
Aug 27

Biocytogen Pharmaceuticals H1 Revenue up 51.6%

Reuters
·
Aug 27

Hansoh Pharmaceutical Group Stock Advances 16% in Hong Kong

Dow Jones
·
Aug 27

China's Hansoh Pharmaceutical Jumps Most on Record on H1 Profit Growth

Reuters
·
Aug 27

Movement Alert|HANSOH PHARMA Rises 5.73% in Regular Trading, H1 Net Profit Surges 35.8% Year-over-Year

Market Focus
·
Aug 27

Stronger Half Year Earnings And Profitability Could Be A Game Changer For Hansoh (SEHK:3692)

Simply Wall St.
·
Aug 26

Grand Pharmaceutical H1 Revenue Rises on Nuclear Medicine Demand

Reuters
·
Aug 26

HANSOH PHARMA lowers CB conversion price to HK$56.54, potential share issuance up 1.5%

Bulletin Express
·
Aug 26

Hansoh Pharmaceutical Cuts Convertible Bond Conversion Price to Hk$56.54 Per Share

Reuters
·
Aug 26

China's Zhongzhi Pharmaceutical H1 Revenue Falls 10%

Reuters
·
Aug 26

Uni-Bio Science H1 Revenue Falls 12% on Pricing Changes

Reuters
·
Aug 26

Hansoh Pharma Declares HKD 0.285 Interim Dividend for First Half of 2026

Bulletin Express
·
Aug 26

Hansoh Pharma Reports Near 36% Rise in First-Half Profit

Reuters
·
Aug 26

Hansoh Pharma Posts 35.82% Profit Surge in Interim Results

Stock News
·
Aug 26

Hansoh Pharmaceutical Group Company H1 Net Income Attributable RMB 4,257.9 Million

THOMSON REUTERS
·
Aug 26

Hansoh Pharmaceutical Group Declared Payment of an Interim Dividend of Hk$28.50 Cents Per Share for \n Six Months

THOMSON REUTERS
·
Aug 26